Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
3.87B | 4.02B | 3.85B | 3.60B | 3.27B | 3.89B |
Gross Profit | |||||
1.64B | 1.83B | 1.54B | 1.54B | 1.55B | 1.66B |
EBIT | |||||
180.40M | -938.80M | 9.20M | 42.70M | 170.60M | 7.60M |
EBITDA | |||||
1.78B | 912.00M | 141.20M | 1.84B | 1.49B | 1.96B |
Net Income Common Stockholders | |||||
-284.00M | -1.10B | -2.02B | -205.40M | -34.50M | -206.40M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
98.42M | 314.00M | 272.10M | 371.20M | 528.70M | 318.20M |
Total Assets | |||||
1.70B | 7.09B | 7.43B | 8.99B | 8.31B | 7.95B |
Total Debt | |||||
814.91M | 4.42B | 2.02B | 4.11B | 3.33B | 3.18B |
Net Debt | |||||
723.49M | 4.10B | 1.75B | 3.73B | 2.81B | 2.87B |
Total Liabilities | |||||
1.62B | 7.28B | 6.30B | 5.99B | 5.51B | 5.29B |
Stockholders Equity | |||||
53.92M | -312.70M | 784.50M | 2.68B | 2.79B | 2.66B |
Cash Flow | Free Cash Flow | ||||
-397.90M | 362.10M | -163.30M | -694.00M | -35.50M | 583.50M |
Operating Cash Flow | |||||
-364.30M | 396.80M | -114.30M | -660.90M | -500.00K | 614.60M |
Investing Cash Flow | |||||
-57.60M | -376.80M | -18.30M | -80.50M | -31.10M | -51.70M |
Financing Cash Flow | |||||
349.40M | 39.60M | 63.80M | 599.40M | 237.90M | -426.10M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
64 Neutral | $872.05M | 14.88 | 6.01% | ― | -9.84% | -61.26% | |
60 Neutral | $495.65M | ― | -1.66% | 1.73% | 0.82% | -152.64% | |
58 Neutral | $12.88B | 6.77 | -2.53% | 3.86% | 2.36% | -36.74% | |
57 Neutral | $1.15B | 44.87 | 9.10% | ― | -6.04% | 6.43% | |
51 Neutral | $7.69B | ― | -31.94% | 1.83% | -1.48% | -450.15% | |
41 Neutral | $1.91B | ― | 19.96% | ― | ― | -285.78% | |
39 Underperform | $1.79B | ― | 259.47% | ― | -2.85% | 75.96% |